nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—epilepsy syndrome	0.764	1	CbGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—CLCN6—epilepsy syndrome	0.00512	0.0843	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—CLCN6—epilepsy syndrome	0.00334	0.055	CbGpPWpGaD
Lubiprostone—CLCN2—spinal cord—epilepsy syndrome	0.00261	0.136	CbGeAlD
Lubiprostone—CLCN2—head—epilepsy syndrome	0.00232	0.12	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—GABRG2—epilepsy syndrome	0.00215	0.0355	CbGpPWpGaD
Lubiprostone—CLCN2—cerebellum—epilepsy syndrome	0.00207	0.107	CbGeAlD
Lubiprostone—CLCN2—Stimuli-sensing channels—TRPV1—epilepsy syndrome	0.00204	0.0336	CbGpPWpGaD
Lubiprostone—CBR1—Niclosamide—Clonazepam—epilepsy syndrome	0.00172	1	CbGdCrCtD
Lubiprostone—CLCN2—brain—epilepsy syndrome	0.00168	0.0873	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—GABRA5—epilepsy syndrome	0.00163	0.0269	CbGpPWpGaD
Lubiprostone—CBR1—forebrain—epilepsy syndrome	0.00163	0.0844	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—ARHGEF9—epilepsy syndrome	0.00156	0.0258	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—GABRB3—epilepsy syndrome	0.00156	0.0258	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—GABRA1—epilepsy syndrome	0.00156	0.0258	CbGpPWpGaD
Lubiprostone—CBR1—telencephalon—epilepsy syndrome	0.0015	0.0776	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—GABRB2—epilepsy syndrome	0.00139	0.0229	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—TRPV1—epilepsy syndrome	0.00133	0.0219	CbGpPWpGaD
Lubiprostone—CBR1—medulla oblongata—epilepsy syndrome	0.00117	0.0609	CbGeAlD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00116	0.0192	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.00108	0.0177	CbGpPWpGaD
Lubiprostone—CBR1—midbrain—epilepsy syndrome	0.00107	0.0557	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00105	0.0173	CbGpPWpGaD
Lubiprostone—CBR1—spinal cord—epilepsy syndrome	0.00105	0.0543	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—epilepsy syndrome	0.00105	0.0172	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00104	0.0171	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00104	0.0171	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00104	0.0171	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—ATP2A2—epilepsy syndrome	0.000982	0.0162	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000948	0.0156	CbGpPWpGaD
Lubiprostone—CBR1—head—epilepsy syndrome	0.000931	0.0483	CbGeAlD
Lubiprostone—CBR1—nervous system—epilepsy syndrome	0.000883	0.0458	CbGeAlD
Lubiprostone—CBR1—central nervous system—epilepsy syndrome	0.00085	0.0441	CbGeAlD
Lubiprostone—CBR1—cerebellum—epilepsy syndrome	0.000831	0.0431	CbGeAlD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000828	0.0136	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000785	0.0129	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000785	0.0129	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000785	0.0129	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000749	0.0123	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000749	0.0123	CbGpPWpGaD
Lubiprostone—Dinoprostone—SLCO1A2—epilepsy syndrome	0.000744	0.535	CrCbGaD
Lubiprostone—CBR1—brain—epilepsy syndrome	0.000675	0.035	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000655	0.0108	CbGpPWpGaD
Lubiprostone—Dinoprostone—CYP11A1—epilepsy syndrome	0.000647	0.465	CrCbGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—epilepsy syndrome	0.000641	0.0106	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000611	0.0101	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000595	0.00981	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000595	0.00981	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000568	0.00935	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000552	0.00909	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000544	0.00897	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000544	0.00897	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000544	0.00897	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000544	0.00897	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000513	0.00845	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000506	0.00834	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000483	0.00795	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000476	0.00784	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000467	0.00769	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000467	0.00769	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000463	0.00763	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000445	0.00734	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.00043	0.00709	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.00043	0.00709	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000412	0.0068	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.00041	0.00675	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000383	0.00632	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	0.000378	0.00622	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000371	0.00611	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000354	0.00583	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000351	0.00578	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000349	0.00574	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000342	0.00563	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000323	0.00533	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000311	0.00513	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—epilepsy syndrome	0.000305	0.00502	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000291	0.00479	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000283	0.00466	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000277	0.00457	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA13—epilepsy syndrome	0.000274	0.00452	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000228	0.00376	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000226	0.00372	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000221	0.00364	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000219	0.00361	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CERS1—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PDXK—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FAR1—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ADK—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GLUD1—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—L2HGDH—epilepsy syndrome	0.000208	0.00342	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GAMT—epilepsy syndrome	0.00019	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PNPO—epilepsy syndrome	0.00019	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—EPM2A—epilepsy syndrome	0.00019	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NHLRC1—epilepsy syndrome	0.00019	0.00313	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CA4—epilepsy syndrome	0.000177	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—QDPR—epilepsy syndrome	0.000177	0.00291	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—COX3—epilepsy syndrome	0.000166	0.00274	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—KCNB1—epilepsy syndrome	0.000157	0.0026	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CACNA2D2—epilepsy syndrome	0.000157	0.0026	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC6A8—epilepsy syndrome	0.000157	0.0026	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLCO1A2—epilepsy syndrome	0.000157	0.0026	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PFKL—epilepsy syndrome	0.000157	0.0026	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000154	0.00254	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000153	0.00252	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ATIC—epilepsy syndrome	0.000144	0.00237	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NEU1—epilepsy syndrome	0.000144	0.00237	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UPB1—epilepsy syndrome	0.000144	0.00237	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD17B4—epilepsy syndrome	0.000139	0.00228	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	0.000137	0.00226	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GBE1—epilepsy syndrome	0.000134	0.00221	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPP1R3C—epilepsy syndrome	0.000134	0.00221	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000131	0.00216	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ASAH1—epilepsy syndrome	0.000126	0.00207	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—STXBP1—epilepsy syndrome	0.000122	0.00202	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NT5E—epilepsy syndrome	0.000119	0.00197	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALAD—epilepsy syndrome	0.000119	0.00197	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH7A1—epilepsy syndrome	0.000114	0.00188	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CACNA1A—epilepsy syndrome	0.000114	0.00188	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ST3GAL3—epilepsy syndrome	0.000111	0.00184	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ADSL—epilepsy syndrome	0.000109	0.0018	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GLUL—epilepsy syndrome	0.000107	0.00176	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CACNA1D—epilepsy syndrome	0.000105	0.00173	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TXNRD1—epilepsy syndrome	9.83e-05	0.00162	CbGpPWpGaD
Lubiprostone—Vomiting—Levetiracetam—epilepsy syndrome	9.79e-05	0.00064	CcSEcCtD
Lubiprostone—Discomfort—Valproic Acid—epilepsy syndrome	9.77e-05	0.000639	CcSEcCtD
Lubiprostone—Headache—Midazolam—epilepsy syndrome	9.77e-05	0.000639	CcSEcCtD
Lubiprostone—Abdominal pain—Carbamazepine—epilepsy syndrome	9.76e-05	0.000638	CcSEcCtD
Lubiprostone—Diarrhoea—Diazepam—epilepsy syndrome	9.76e-05	0.000638	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	9.76e-05	0.000638	CcSEcCtD
Lubiprostone—Ill-defined disorder—Pregabalin—epilepsy syndrome	9.75e-05	0.000637	CcSEcCtD
Lubiprostone—Rash—Levetiracetam—epilepsy syndrome	9.71e-05	0.000635	CcSEcCtD
Lubiprostone—Dermatitis—Levetiracetam—epilepsy syndrome	9.7e-05	0.000635	CcSEcCtD
Lubiprostone—Asthenia—Zonisamide—epilepsy syndrome	9.69e-05	0.000634	CcSEcCtD
Lubiprostone—Mental disorder—Gabapentin—epilepsy syndrome	9.69e-05	0.000634	CcSEcCtD
Lubiprostone—Dry mouth—Valproic Acid—epilepsy syndrome	9.67e-05	0.000633	CcSEcCtD
Lubiprostone—Headache—Levetiracetam—epilepsy syndrome	9.65e-05	0.000631	CcSEcCtD
Lubiprostone—Malnutrition—Gabapentin—epilepsy syndrome	9.63e-05	0.00063	CcSEcCtD
Lubiprostone—Erythema—Gabapentin—epilepsy syndrome	9.63e-05	0.00063	CcSEcCtD
Lubiprostone—Hypersensitivity—Clonazepam—epilepsy syndrome	9.59e-05	0.000628	CcSEcCtD
Lubiprostone—Dizziness—Vigabatrin—epilepsy syndrome	9.58e-05	0.000627	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AQP1—epilepsy syndrome	9.54e-05	0.00157	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Phenytoin—epilepsy syndrome	9.53e-05	0.000623	CcSEcCtD
Lubiprostone—Flatulence—Gabapentin—epilepsy syndrome	9.49e-05	0.000621	CcSEcCtD
Lubiprostone—Oedema—Valproic Acid—epilepsy syndrome	9.48e-05	0.00062	CcSEcCtD
Lubiprostone—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.48e-05	0.00062	CcSEcCtD
Lubiprostone—Malaise—Pregabalin—epilepsy syndrome	9.47e-05	0.00062	CcSEcCtD
Lubiprostone—Nausea—Propofol—epilepsy syndrome	9.47e-05	0.000619	CcSEcCtD
Lubiprostone—Vomiting—Fosphenytoin—epilepsy syndrome	9.45e-05	0.000618	CcSEcCtD
Lubiprostone—Diarrhoea—Felbamate—epilepsy syndrome	9.44e-05	0.000618	CcSEcCtD
Lubiprostone—Abdominal pain—Lamotrigine—epilepsy syndrome	9.43e-05	0.000617	CcSEcCtD
Lubiprostone—Dysgeusia—Gabapentin—epilepsy syndrome	9.43e-05	0.000617	CcSEcCtD
Lubiprostone—Dizziness—Diazepam—epilepsy syndrome	9.43e-05	0.000617	CcSEcCtD
Lubiprostone—Syncope—Pregabalin—epilepsy syndrome	9.42e-05	0.000616	CcSEcCtD
Lubiprostone—Rash—Fosphenytoin—epilepsy syndrome	9.37e-05	0.000613	CcSEcCtD
Lubiprostone—Dermatitis—Fosphenytoin—epilepsy syndrome	9.36e-05	0.000612	CcSEcCtD
Lubiprostone—Asthenia—Clonazepam—epilepsy syndrome	9.34e-05	0.000611	CcSEcCtD
Lubiprostone—Headache—Fosphenytoin—epilepsy syndrome	9.31e-05	0.000609	CcSEcCtD
Lubiprostone—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.3e-05	0.000608	CcSEcCtD
Lubiprostone—Palpitations—Pregabalin—epilepsy syndrome	9.28e-05	0.000607	CcSEcCtD
Lubiprostone—Asthenia—Phenytoin—epilepsy syndrome	9.28e-05	0.000607	CcSEcCtD
Lubiprostone—Nausea—Midazolam—epilepsy syndrome	9.26e-05	0.000606	CcSEcCtD
Lubiprostone—Muscle spasms—Gabapentin—epilepsy syndrome	9.26e-05	0.000606	CcSEcCtD
Lubiprostone—Tachycardia—Valproic Acid—epilepsy syndrome	9.25e-05	0.000605	CcSEcCtD
Lubiprostone—Diarrhoea—Zonisamide—epilepsy syndrome	9.24e-05	0.000605	CcSEcCtD
Lubiprostone—Loss of consciousness—Pregabalin—epilepsy syndrome	9.23e-05	0.000604	CcSEcCtD
Lubiprostone—Asthenia—Oxcarbazepine—epilepsy syndrome	9.23e-05	0.000604	CcSEcCtD
Lubiprostone—Vomiting—Vigabatrin—epilepsy syndrome	9.21e-05	0.000602	CcSEcCtD
Lubiprostone—Skin disorder—Valproic Acid—epilepsy syndrome	9.21e-05	0.000602	CcSEcCtD
Lubiprostone—Oedema peripheral—Topiramate—epilepsy syndrome	9.17e-05	0.0006	CcSEcCtD
Lubiprostone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.17e-05	0.0006	CcSEcCtD
Lubiprostone—Cough—Pregabalin—epilepsy syndrome	9.17e-05	0.0006	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	9.16e-05	0.00151	CbGpPWpGaD
Lubiprostone—Connective tissue disorder—Topiramate—epilepsy syndrome	9.15e-05	0.000598	CcSEcCtD
Lubiprostone—Nausea—Levetiracetam—epilepsy syndrome	9.15e-05	0.000598	CcSEcCtD
Lubiprostone—Rash—Vigabatrin—epilepsy syndrome	9.13e-05	0.000597	CcSEcCtD
Lubiprostone—Dizziness—Felbamate—epilepsy syndrome	9.13e-05	0.000597	CcSEcCtD
Lubiprostone—Dermatitis—Vigabatrin—epilepsy syndrome	9.13e-05	0.000597	CcSEcCtD
Lubiprostone—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.1e-05	0.000595	CcSEcCtD
Lubiprostone—Headache—Vigabatrin—epilepsy syndrome	9.08e-05	0.000594	CcSEcCtD
Lubiprostone—Vomiting—Diazepam—epilepsy syndrome	9.07e-05	0.000593	CcSEcCtD
Lubiprostone—Anorexia—Valproic Acid—epilepsy syndrome	9.04e-05	0.000591	CcSEcCtD
Lubiprostone—Tremor—Gabapentin—epilepsy syndrome	9.02e-05	0.00059	CcSEcCtD
Lubiprostone—Rash—Diazepam—epilepsy syndrome	8.99e-05	0.000588	CcSEcCtD
Lubiprostone—Dermatitis—Diazepam—epilepsy syndrome	8.98e-05	0.000588	CcSEcCtD
Lubiprostone—Chest pain—Pregabalin—epilepsy syndrome	8.94e-05	0.000585	CcSEcCtD
Lubiprostone—Myalgia—Pregabalin—epilepsy syndrome	8.94e-05	0.000585	CcSEcCtD
Lubiprostone—Ill-defined disorder—Gabapentin—epilepsy syndrome	8.94e-05	0.000585	CcSEcCtD
Lubiprostone—Dizziness—Zonisamide—epilepsy syndrome	8.94e-05	0.000584	CcSEcCtD
Lubiprostone—Headache—Diazepam—epilepsy syndrome	8.93e-05	0.000584	CcSEcCtD
Lubiprostone—Anxiety—Pregabalin—epilepsy syndrome	8.91e-05	0.000583	CcSEcCtD
Lubiprostone—Diarrhoea—Clonazepam—epilepsy syndrome	8.91e-05	0.000583	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.88e-05	0.000581	CcSEcCtD
Lubiprostone—Asthenia—Carbamazepine—epilepsy syndrome	8.86e-05	0.000579	CcSEcCtD
Lubiprostone—Diarrhoea—Phenytoin—epilepsy syndrome	8.85e-05	0.000579	CcSEcCtD
Lubiprostone—Discomfort—Pregabalin—epilepsy syndrome	8.84e-05	0.000578	CcSEcCtD
Lubiprostone—Nausea—Fosphenytoin—epilepsy syndrome	8.83e-05	0.000577	CcSEcCtD
Lubiprostone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.8e-05	0.000576	CcSEcCtD
Lubiprostone—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.79e-05	0.000575	CcSEcCtD
Lubiprostone—Vomiting—Felbamate—epilepsy syndrome	8.78e-05	0.000574	CcSEcCtD
Lubiprostone—Dry mouth—Pregabalin—epilepsy syndrome	8.75e-05	0.000572	CcSEcCtD
Lubiprostone—Rash—Felbamate—epilepsy syndrome	8.7e-05	0.000569	CcSEcCtD
Lubiprostone—Dermatitis—Felbamate—epilepsy syndrome	8.7e-05	0.000569	CcSEcCtD
Lubiprostone—Malaise—Gabapentin—epilepsy syndrome	8.69e-05	0.000568	CcSEcCtD
Lubiprostone—Headache—Felbamate—epilepsy syndrome	8.65e-05	0.000566	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.64e-05	0.000565	CcSEcCtD
Lubiprostone—Syncope—Gabapentin—epilepsy syndrome	8.64e-05	0.000565	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CHRM3—epilepsy syndrome	8.63e-05	0.00142	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—KCNJ11—epilepsy syndrome	8.63e-05	0.00142	CbGpPWpGaD
Lubiprostone—Dizziness—Clonazepam—epilepsy syndrome	8.61e-05	0.000563	CcSEcCtD
Lubiprostone—Nausea—Vigabatrin—epilepsy syndrome	8.6e-05	0.000563	CcSEcCtD
Lubiprostone—Vomiting—Zonisamide—epilepsy syndrome	8.59e-05	0.000562	CcSEcCtD
Lubiprostone—Oedema—Pregabalin—epilepsy syndrome	8.57e-05	0.000561	CcSEcCtD
Lubiprostone—Asthenia—Lamotrigine—epilepsy syndrome	8.56e-05	0.00056	CcSEcCtD
Lubiprostone—Dizziness—Phenytoin—epilepsy syndrome	8.55e-05	0.00056	CcSEcCtD
Lubiprostone—Rash—Zonisamide—epilepsy syndrome	8.52e-05	0.000557	CcSEcCtD
Lubiprostone—Palpitations—Gabapentin—epilepsy syndrome	8.51e-05	0.000557	CcSEcCtD
Lubiprostone—Dermatitis—Zonisamide—epilepsy syndrome	8.51e-05	0.000557	CcSEcCtD
Lubiprostone—Dizziness—Oxcarbazepine—epilepsy syndrome	8.51e-05	0.000557	CcSEcCtD
Lubiprostone—Nausea—Diazepam—epilepsy syndrome	8.47e-05	0.000554	CcSEcCtD
Lubiprostone—Loss of consciousness—Gabapentin—epilepsy syndrome	8.47e-05	0.000554	CcSEcCtD
Lubiprostone—Headache—Zonisamide—epilepsy syndrome	8.46e-05	0.000554	CcSEcCtD
Lubiprostone—Dyspnoea—Valproic Acid—epilepsy syndrome	8.45e-05	0.000553	CcSEcCtD
Lubiprostone—Diarrhoea—Carbamazepine—epilepsy syndrome	8.45e-05	0.000553	CcSEcCtD
Lubiprostone—Shock—Pregabalin—epilepsy syndrome	8.43e-05	0.000552	CcSEcCtD
Lubiprostone—Nervous system disorder—Pregabalin—epilepsy syndrome	8.41e-05	0.00055	CcSEcCtD
Lubiprostone—Cough—Gabapentin—epilepsy syndrome	8.4e-05	0.00055	CcSEcCtD
Lubiprostone—Mediastinal disorder—Topiramate—epilepsy syndrome	8.39e-05	0.000549	CcSEcCtD
Lubiprostone—Tachycardia—Pregabalin—epilepsy syndrome	8.37e-05	0.000547	CcSEcCtD
Lubiprostone—Dyspepsia—Valproic Acid—epilepsy syndrome	8.35e-05	0.000546	CcSEcCtD
Lubiprostone—Skin disorder—Pregabalin—epilepsy syndrome	8.33e-05	0.000545	CcSEcCtD
Lubiprostone—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.29e-05	0.000542	CcSEcCtD
Lubiprostone—Vomiting—Clonazepam—epilepsy syndrome	8.28e-05	0.000542	CcSEcCtD
Lubiprostone—Decreased appetite—Valproic Acid—epilepsy syndrome	8.24e-05	0.000539	CcSEcCtD
Lubiprostone—Vomiting—Phenytoin—epilepsy syndrome	8.22e-05	0.000538	CcSEcCtD
Lubiprostone—Rash—Clonazepam—epilepsy syndrome	8.21e-05	0.000537	CcSEcCtD
Lubiprostone—Dermatitis—Clonazepam—epilepsy syndrome	8.2e-05	0.000537	CcSEcCtD
Lubiprostone—Chest pain—Gabapentin—epilepsy syndrome	8.2e-05	0.000536	CcSEcCtD
Lubiprostone—Myalgia—Gabapentin—epilepsy syndrome	8.2e-05	0.000536	CcSEcCtD
Lubiprostone—Nausea—Felbamate—epilepsy syndrome	8.2e-05	0.000536	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.19e-05	0.000535	CcSEcCtD
Lubiprostone—Vomiting—Oxcarbazepine—epilepsy syndrome	8.18e-05	0.000535	CcSEcCtD
Lubiprostone—Fatigue—Valproic Acid—epilepsy syndrome	8.18e-05	0.000535	CcSEcCtD
Lubiprostone—Anxiety—Gabapentin—epilepsy syndrome	8.17e-05	0.000535	CcSEcCtD
Lubiprostone—Anorexia—Pregabalin—epilepsy syndrome	8.17e-05	0.000535	CcSEcCtD
Lubiprostone—Dizziness—Carbamazepine—epilepsy syndrome	8.16e-05	0.000534	CcSEcCtD
Lubiprostone—Diarrhoea—Lamotrigine—epilepsy syndrome	8.16e-05	0.000534	CcSEcCtD
Lubiprostone—Headache—Clonazepam—epilepsy syndrome	8.16e-05	0.000534	CcSEcCtD
Lubiprostone—Rash—Phenytoin—epilepsy syndrome	8.16e-05	0.000533	CcSEcCtD
Lubiprostone—Mental disorder—Topiramate—epilepsy syndrome	8.16e-05	0.000533	CcSEcCtD
Lubiprostone—Dermatitis—Phenytoin—epilepsy syndrome	8.15e-05	0.000533	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.14e-05	0.000533	CcSEcCtD
Lubiprostone—Rash—Oxcarbazepine—epilepsy syndrome	8.11e-05	0.000531	CcSEcCtD
Lubiprostone—Pain—Valproic Acid—epilepsy syndrome	8.11e-05	0.00053	CcSEcCtD
Lubiprostone—Constipation—Valproic Acid—epilepsy syndrome	8.11e-05	0.00053	CcSEcCtD
Lubiprostone—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.11e-05	0.00053	CcSEcCtD
Lubiprostone—Headache—Phenytoin—epilepsy syndrome	8.1e-05	0.00053	CcSEcCtD
Lubiprostone—Erythema—Topiramate—epilepsy syndrome	8.1e-05	0.00053	CcSEcCtD
Lubiprostone—Malnutrition—Topiramate—epilepsy syndrome	8.1e-05	0.00053	CcSEcCtD
Lubiprostone—Discomfort—Gabapentin—epilepsy syndrome	8.1e-05	0.00053	CcSEcCtD
Lubiprostone—Headache—Oxcarbazepine—epilepsy syndrome	8.06e-05	0.000527	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	8.04e-05	0.00132	CbGpPWpGaD
Lubiprostone—Nausea—Zonisamide—epilepsy syndrome	8.03e-05	0.000525	CcSEcCtD
Lubiprostone—Dry mouth—Gabapentin—epilepsy syndrome	8.02e-05	0.000525	CcSEcCtD
Lubiprostone—Flatulence—Topiramate—epilepsy syndrome	7.98e-05	0.000522	CcSEcCtD
Lubiprostone—Dysgeusia—Topiramate—epilepsy syndrome	7.94e-05	0.000519	CcSEcCtD
Lubiprostone—Dizziness—Lamotrigine—epilepsy syndrome	7.89e-05	0.000516	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.87e-05	0.0013	CbGpPWpGaD
Lubiprostone—Oedema—Gabapentin—epilepsy syndrome	7.86e-05	0.000514	CcSEcCtD
Lubiprostone—Vomiting—Carbamazepine—epilepsy syndrome	7.85e-05	0.000514	CcSEcCtD
Lubiprostone—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.81e-05	0.000511	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.81e-05	0.000511	CcSEcCtD
Lubiprostone—Muscle spasms—Topiramate—epilepsy syndrome	7.79e-05	0.00051	CcSEcCtD
Lubiprostone—Rash—Carbamazepine—epilepsy syndrome	7.79e-05	0.000509	CcSEcCtD
Lubiprostone—Dermatitis—Carbamazepine—epilepsy syndrome	7.78e-05	0.000509	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.75e-05	0.000507	CcSEcCtD
Lubiprostone—Nausea—Clonazepam—epilepsy syndrome	7.74e-05	0.000506	CcSEcCtD
Lubiprostone—Headache—Carbamazepine—epilepsy syndrome	7.73e-05	0.000506	CcSEcCtD
Lubiprostone—Shock—Gabapentin—epilepsy syndrome	7.73e-05	0.000506	CcSEcCtD
Lubiprostone—Nervous system disorder—Gabapentin—epilepsy syndrome	7.71e-05	0.000504	CcSEcCtD
Lubiprostone—Nausea—Phenytoin—epilepsy syndrome	7.68e-05	0.000503	CcSEcCtD
Lubiprostone—Tachycardia—Gabapentin—epilepsy syndrome	7.67e-05	0.000502	CcSEcCtD
Lubiprostone—Dyspnoea—Pregabalin—epilepsy syndrome	7.64e-05	0.0005	CcSEcCtD
Lubiprostone—Nausea—Oxcarbazepine—epilepsy syndrome	7.64e-05	0.0005	CcSEcCtD
Lubiprostone—Skin disorder—Gabapentin—epilepsy syndrome	7.64e-05	0.000499	CcSEcCtD
Lubiprostone—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.6e-05	0.000497	CcSEcCtD
Lubiprostone—Tremor—Topiramate—epilepsy syndrome	7.59e-05	0.000497	CcSEcCtD
Lubiprostone—Vomiting—Lamotrigine—epilepsy syndrome	7.59e-05	0.000496	CcSEcCtD
Lubiprostone—Rash—Lamotrigine—epilepsy syndrome	7.52e-05	0.000492	CcSEcCtD
Lubiprostone—Ill-defined disorder—Topiramate—epilepsy syndrome	7.52e-05	0.000492	CcSEcCtD
Lubiprostone—Dermatitis—Lamotrigine—epilepsy syndrome	7.52e-05	0.000492	CcSEcCtD
Lubiprostone—Abdominal pain—Valproic Acid—epilepsy syndrome	7.5e-05	0.00049	CcSEcCtD
Lubiprostone—Anorexia—Gabapentin—epilepsy syndrome	7.49e-05	0.00049	CcSEcCtD
Lubiprostone—Headache—Lamotrigine—epilepsy syndrome	7.48e-05	0.000489	CcSEcCtD
Lubiprostone—Decreased appetite—Pregabalin—epilepsy syndrome	7.45e-05	0.000487	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.4e-05	0.000484	CcSEcCtD
Lubiprostone—Fatigue—Pregabalin—epilepsy syndrome	7.39e-05	0.000483	CcSEcCtD
Lubiprostone—Nausea—Carbamazepine—epilepsy syndrome	7.33e-05	0.00048	CcSEcCtD
Lubiprostone—Pain—Pregabalin—epilepsy syndrome	7.33e-05	0.00048	CcSEcCtD
Lubiprostone—Constipation—Pregabalin—epilepsy syndrome	7.33e-05	0.00048	CcSEcCtD
Lubiprostone—Malaise—Topiramate—epilepsy syndrome	7.31e-05	0.000478	CcSEcCtD
Lubiprostone—Syncope—Topiramate—epilepsy syndrome	7.27e-05	0.000475	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.16e-05	0.000468	CcSEcCtD
Lubiprostone—Palpitations—Topiramate—epilepsy syndrome	7.16e-05	0.000468	CcSEcCtD
Lubiprostone—Loss of consciousness—Topiramate—epilepsy syndrome	7.12e-05	0.000466	CcSEcCtD
Lubiprostone—Nausea—Lamotrigine—epilepsy syndrome	7.09e-05	0.000464	CcSEcCtD
Lubiprostone—Cough—Topiramate—epilepsy syndrome	7.07e-05	0.000463	CcSEcCtD
Lubiprostone—Feeling abnormal—Pregabalin—epilepsy syndrome	7.06e-05	0.000462	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ABCG2—epilepsy syndrome	7.03e-05	0.00116	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.01e-05	0.000459	CcSEcCtD
Lubiprostone—Dyspnoea—Gabapentin—epilepsy syndrome	7.01e-05	0.000458	CcSEcCtD
Lubiprostone—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.99e-05	0.000457	CcSEcCtD
Lubiprostone—Dyspepsia—Gabapentin—epilepsy syndrome	6.92e-05	0.000453	CcSEcCtD
Lubiprostone—Chest pain—Topiramate—epilepsy syndrome	6.9e-05	0.000451	CcSEcCtD
Lubiprostone—Myalgia—Topiramate—epilepsy syndrome	6.9e-05	0.000451	CcSEcCtD
Lubiprostone—Anxiety—Topiramate—epilepsy syndrome	6.87e-05	0.00045	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2C19—epilepsy syndrome	6.86e-05	0.00113	CbGpPWpGaD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.85e-05	0.000448	CcSEcCtD
Lubiprostone—Decreased appetite—Gabapentin—epilepsy syndrome	6.83e-05	0.000447	CcSEcCtD
Lubiprostone—Discomfort—Topiramate—epilepsy syndrome	6.82e-05	0.000446	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP11A1—epilepsy syndrome	6.81e-05	0.00112	CbGpPWpGaD
Lubiprostone—Asthenia—Valproic Acid—epilepsy syndrome	6.8e-05	0.000445	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.79e-05	0.000444	CcSEcCtD
Lubiprostone—Fatigue—Gabapentin—epilepsy syndrome	6.78e-05	0.000443	CcSEcCtD
Lubiprostone—Abdominal pain—Pregabalin—epilepsy syndrome	6.78e-05	0.000443	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.76e-05	0.00111	CbGpPWpGaD
Lubiprostone—Dry mouth—Topiramate—epilepsy syndrome	6.75e-05	0.000441	CcSEcCtD
Lubiprostone—Constipation—Gabapentin—epilepsy syndrome	6.72e-05	0.00044	CcSEcCtD
Lubiprostone—Pain—Gabapentin—epilepsy syndrome	6.72e-05	0.00044	CcSEcCtD
Lubiprostone—Oedema—Topiramate—epilepsy syndrome	6.61e-05	0.000433	CcSEcCtD
Lubiprostone—Shock—Topiramate—epilepsy syndrome	6.51e-05	0.000426	CcSEcCtD
Lubiprostone—Diarrhoea—Valproic Acid—epilepsy syndrome	6.49e-05	0.000424	CcSEcCtD
Lubiprostone—Nervous system disorder—Topiramate—epilepsy syndrome	6.49e-05	0.000424	CcSEcCtD
Lubiprostone—Feeling abnormal—Gabapentin—epilepsy syndrome	6.48e-05	0.000424	CcSEcCtD
Lubiprostone—Tachycardia—Topiramate—epilepsy syndrome	6.45e-05	0.000422	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.43e-05	0.00042	CcSEcCtD
Lubiprostone—Skin disorder—Topiramate—epilepsy syndrome	6.42e-05	0.00042	CcSEcCtD
Lubiprostone—Hyperhidrosis—Topiramate—epilepsy syndrome	6.39e-05	0.000418	CcSEcCtD
Lubiprostone—Hypersensitivity—Pregabalin—epilepsy syndrome	6.32e-05	0.000413	CcSEcCtD
Lubiprostone—Anorexia—Topiramate—epilepsy syndrome	6.3e-05	0.000412	CcSEcCtD
Lubiprostone—Dizziness—Valproic Acid—epilepsy syndrome	6.27e-05	0.00041	CcSEcCtD
Lubiprostone—Abdominal pain—Gabapentin—epilepsy syndrome	6.21e-05	0.000406	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.17e-05	0.00102	CbGpPWpGaD
Lubiprostone—Asthenia—Pregabalin—epilepsy syndrome	6.15e-05	0.000402	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2D6—epilepsy syndrome	6.15e-05	0.00101	CbGpPWpGaD
Lubiprostone—Vomiting—Valproic Acid—epilepsy syndrome	6.03e-05	0.000394	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.03e-05	0.000394	CcSEcCtD
Lubiprostone—Rash—Valproic Acid—epilepsy syndrome	5.98e-05	0.000391	CcSEcCtD
Lubiprostone—Dermatitis—Valproic Acid—epilepsy syndrome	5.97e-05	0.000391	CcSEcCtD
Lubiprostone—Headache—Valproic Acid—epilepsy syndrome	5.94e-05	0.000389	CcSEcCtD
Lubiprostone—Dyspnoea—Topiramate—epilepsy syndrome	5.9e-05	0.000386	CcSEcCtD
Lubiprostone—Diarrhoea—Pregabalin—epilepsy syndrome	5.87e-05	0.000384	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADRA2A—epilepsy syndrome	5.85e-05	0.000964	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BCHE—epilepsy syndrome	5.83e-05	0.00096	CbGpPWpGaD
Lubiprostone—Dyspepsia—Topiramate—epilepsy syndrome	5.82e-05	0.000381	CcSEcCtD
Lubiprostone—Hypersensitivity—Gabapentin—epilepsy syndrome	5.79e-05	0.000379	CcSEcCtD
Lubiprostone—Decreased appetite—Topiramate—epilepsy syndrome	5.75e-05	0.000376	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.71e-05	0.000373	CcSEcCtD
Lubiprostone—Fatigue—Topiramate—epilepsy syndrome	5.7e-05	0.000373	CcSEcCtD
Lubiprostone—Dizziness—Pregabalin—epilepsy syndrome	5.67e-05	0.000371	CcSEcCtD
Lubiprostone—Pain—Topiramate—epilepsy syndrome	5.66e-05	0.00037	CcSEcCtD
Lubiprostone—Constipation—Topiramate—epilepsy syndrome	5.66e-05	0.00037	CcSEcCtD
Lubiprostone—Asthenia—Gabapentin—epilepsy syndrome	5.64e-05	0.000369	CcSEcCtD
Lubiprostone—Nausea—Valproic Acid—epilepsy syndrome	5.63e-05	0.000368	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC2A1—epilepsy syndrome	5.56e-05	0.000916	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLCB1—epilepsy syndrome	5.5e-05	0.000906	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—TH—epilepsy syndrome	5.48e-05	0.000903	CbGpPWpGaD
Lubiprostone—Vomiting—Pregabalin—epilepsy syndrome	5.45e-05	0.000357	CcSEcCtD
Lubiprostone—Feeling abnormal—Topiramate—epilepsy syndrome	5.45e-05	0.000356	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.41e-05	0.000354	CcSEcCtD
Lubiprostone—Rash—Pregabalin—epilepsy syndrome	5.41e-05	0.000354	CcSEcCtD
Lubiprostone—Dermatitis—Pregabalin—epilepsy syndrome	5.4e-05	0.000353	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.4e-05	0.000889	CbGpPWpGaD
Lubiprostone—Diarrhoea—Gabapentin—epilepsy syndrome	5.38e-05	0.000352	CcSEcCtD
Lubiprostone—Headache—Pregabalin—epilepsy syndrome	5.37e-05	0.000351	CcSEcCtD
Lubiprostone—Abdominal pain—Topiramate—epilepsy syndrome	5.23e-05	0.000342	CcSEcCtD
Lubiprostone—Dizziness—Gabapentin—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Lubiprostone—Nausea—Pregabalin—epilepsy syndrome	5.09e-05	0.000333	CcSEcCtD
Lubiprostone—Vomiting—Gabapentin—epilepsy syndrome	5e-05	0.000327	CcSEcCtD
Lubiprostone—Rash—Gabapentin—epilepsy syndrome	4.96e-05	0.000324	CcSEcCtD
Lubiprostone—Dermatitis—Gabapentin—epilepsy syndrome	4.95e-05	0.000324	CcSEcCtD
Lubiprostone—Headache—Gabapentin—epilepsy syndrome	4.92e-05	0.000322	CcSEcCtD
Lubiprostone—Hypersensitivity—Topiramate—epilepsy syndrome	4.87e-05	0.000319	CcSEcCtD
Lubiprostone—Asthenia—Topiramate—epilepsy syndrome	4.74e-05	0.00031	CcSEcCtD
Lubiprostone—Nausea—Gabapentin—epilepsy syndrome	4.67e-05	0.000305	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HMOX1—epilepsy syndrome	4.57e-05	0.000754	CbGpPWpGaD
Lubiprostone—Diarrhoea—Topiramate—epilepsy syndrome	4.52e-05	0.000296	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CAT—epilepsy syndrome	4.51e-05	0.000744	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCB1—epilepsy syndrome	4.39e-05	0.000723	CbGpPWpGaD
Lubiprostone—Dizziness—Topiramate—epilepsy syndrome	4.37e-05	0.000286	CcSEcCtD
Lubiprostone—Vomiting—Topiramate—epilepsy syndrome	4.2e-05	0.000275	CcSEcCtD
Lubiprostone—Rash—Topiramate—epilepsy syndrome	4.17e-05	0.000273	CcSEcCtD
Lubiprostone—Dermatitis—Topiramate—epilepsy syndrome	4.17e-05	0.000273	CcSEcCtD
Lubiprostone—Headache—Topiramate—epilepsy syndrome	4.14e-05	0.000271	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GPX1—epilepsy syndrome	4.08e-05	0.000673	CbGpPWpGaD
Lubiprostone—Nausea—Topiramate—epilepsy syndrome	3.93e-05	0.000257	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AGT—epilepsy syndrome	3.58e-05	0.00059	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOE—epilepsy syndrome	3.51e-05	0.000578	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—POMC—epilepsy syndrome	3.01e-05	0.000496	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALB—epilepsy syndrome	2.75e-05	0.000453	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—epilepsy syndrome	2.4e-05	0.000396	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—epilepsy syndrome	1.21e-05	0.000199	CbGpPWpGaD
